Literature DB >> 9544450

Elimination of alkaline phosphatases from circulation by the galactose receptor. Different isoforms are cleared at various rates.

E Blom1, M M Ali, B Mortensen, N E Huseby.   

Abstract

Three isoforms of human alkaline phosphatase (liver, bone and placental ALP) were purified and their elimination studied after intravenous injection in rats. The rates of elimination were significantly inhibited by prior injection of asialofetuin, indicating that the uptake was mediated by the galactose receptor in liver. Their relative clearance rates differed, being rapid for the bone ALP, significantly slower for the liver isoform and very slow for the placental ALP. The bone ALP showed a rapid initial clearance, apparently related to its large glycan heterogeneity and to the presence of molecules with a low sialic acid content. When isolated from serum the liver and bone ALP isoforms showed clearance rates differing slightly from those of the organ derived forms. We conclude that differences in carbohydrate structure and amount of sialic acid of the three isoforms result in various clearance rates. These differences will also affect their serum concentrations as well as the composition and heterogeneity of the individual isoforms in serum.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9544450     DOI: 10.1016/s0009-8981(97)00217-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  12 in total

1.  Extremely high maternal alkaline phosphatase serum concentration with syncytiotrophoblastic origin.

Authors:  A Boronkai; N G Than; R Magenheim; S Bellyei; A Szigeti; P Deres; B Hargitai; B Sumegi; Z Papp; J Rigo
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

2.  Isozyme profile and tissue-origin of alkaline phosphatases in mouse serum.

Authors:  Cecilia Halling Linder; Ulrika H Englund; Sonoko Narisawa; José Luis Millán; Per Magnusson
Journal:  Bone       Date:  2013-01-10       Impact factor: 4.398

3.  Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults.

Authors:  Jonathan M Zenilman; Edward J Fuchs; Craig W Hendrix; Christine Radebaugh; Robert Jurao; Seema U Nayak; Robert G Hamilton; J McLeod Griffiss
Journal:  Antiviral Res       Date:  2015-09-25       Impact factor: 5.970

4.  Intestinal alkaline phosphatase administration in newborns decreases systemic inflammatory cytokine expression in a neonatal necrotizing enterocolitis rat model.

Authors:  Rebecca M Rentea; Jennifer L Liedel; Katherine Fredrich; Scott R Welak; Kirkwood A Pritchard; Keith T Oldham; Pippa M Simpson; David M Gourlay
Journal:  J Surg Res       Date:  2012-06-01       Impact factor: 2.192

5.  Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.

Authors:  Riitta Tähtelä; J Seppänen; K Laitinen; A Katajamäki; J Risteli; M J Välimäki
Journal:  Osteoporos Int       Date:  2004-12-17       Impact factor: 4.507

6.  Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition.

Authors:  Ross F Goldberg; William G Austen; Xiaobo Zhang; Gitonga Munene; Golam Mostafa; Shaluk Biswas; Michael McCormack; Kyle R Eberlin; John T Nguyen; Hamit S Tatlidede; H Shaw Warren; Sonoko Narisawa; Jose L Millán; Richard A Hodin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

7.  A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection.

Authors:  Ronald B Moss; Carrie Hansen; Rebecca L Sanders; Stephen Hawley; Tiejun Li; Roy T Steigbigel
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

8.  A safety evaluation of DAS181, a sialidase fusion protein, in rodents.

Authors:  Jeffrey L Larson; Seong-Kwi Kang; Bo In Choi; Maria Hedlund; Laura M Aschenbrenner; Beth Cecil; Gloriamay Machado; Matthew Nieder; Fang Fang
Journal:  Toxicol Sci       Date:  2011-05-13       Impact factor: 4.849

9.  Alkaline Phosphatase Pathophysiology with Emphasis on the Seldom-Discussed Role of Defective Elimination in Unexplained Elevations of Serum ALP - A Case Report and Literature Review.

Authors:  Michael D Levitt; Sophie M Hapak; David G Levitt
Journal:  Clin Exp Gastroenterol       Date:  2022-03-15

10.  Markers of bone turnover for the management of patients with bone metastases from prostate cancer.

Authors:  P Garnero; N Buchs; J Zekri; R Rizzoli; R E Coleman; P D Delmas
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.